|Articles|October 29, 2012

Dems Tout Impact of Reform Law Drug Program

Congressional Democrats heralded a new Government Accountability Office report (PDF) as proof that the Patient Protection and Affordable Care Act's discount prescription drug program is working as planned.

Starting in January 2011, the law stipulated that drugmakers that want their products covered under Medicare Part D must participate in the drug discount program. Under this provision, the drug manufacturers must provide a 50% discount on the price that Part D plan sponsors negotiate for brand-name drugs when beneficiaries reach the so-called doughnut hole—the gap between the initial and catastrophic coverage periods where Medicare helps pay the costs.

Read the full story: http://tinyurl.com/8n432mf

Source: Modern Healthcare

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo